Cognitive enhancement therapy (CET)

BEHAVIORAL2 trials

Sponsors

Beth Israel Deaconess Medical Center, Nova Scotia Health Authority

Conditions

Alcohol Use DisorderPsychosisSchizophrenia

Phase 3

Cognitive Enhancement Therapy for Early-Stage Schizophrenia

CompletedNCT00167362

Beth Israel Deaconess Medical CenterSchizophrenia

Start: 2001-08-31End: 2016-12-31Updated: 2017-01-10

Unknown Phase

Piloting of an Intervention to Reduce Problematic Alcohol Use in Early Phase Psychosis Patients

RecruitingNCT05365347

Nova Scotia Health AuthorityAlcohol Use Disorder, Psychosis

Start: 2022-12-01End: 2026-12-30Target: 24Updated: 2024-08-23

Related Papers

Piloting of an intervention to reduce problematic alcohol use in early phase psychosis

Psychiatry Research Communications2025-09-23